Albania latest patents query
The latest invention patents collect the data information of Albania invention patents from 2000 to 2024, typesetting according to the date of patent publication, including patent number, application date, invention Bibliographic data, abstracts, and specification data of people are convenient for scientific researchers to quickly browse and search for patents.
Radiotherapy with diffuse alpha emitters with enhanced beta treatment
ActiveAL13556BRadical radiotherapyParticle physics
Owner:ALPHA TAU MEDICAL LTD
Pyrrolo[1,2 b] 2 pyridazinone compounds as 5 ht4 receptor agonists
ActiveAL13544BPyridazine5-HT4 receptor
Owner:SUVEN LIFE SCI LTD
Automated storage systems, assemblies, apparatus and methods for assembling mixed pallets and facilitating order picking
ActiveAL13579BSoftware engineeringPallet
Owner:NEWTEQ HLDG BV
Method for preparation of 4-(4-(4-(((2-(2,6-dioxopiperidin-3-yl)-l-oxoisoindolin-4-yl)oxy)methyl)benzyl)piperazin-l-yl)-3- fluorobenzonitrile
ActiveAL13538BCombinatorial chemistryPiperazidine
Owner:CELGENE CORP
Small molecule inhibitors of the kras g12c mutant
ActiveAL13555BKRASCell biology
Owner:MERCK SHARP & DOHME LLC
Radiopharmaceutical complexes targeting prostate-specific membrane antigen and combinations thereof
ActiveAL13552BAntigenPharmacy medicine
Owner:BAYER AG +1
Use of myostatin inhibitors for the treatment of spinal muscular atrophy
ActiveAL13535BSpinal cordDepressant
Owner:SCHOLAR ROCK INC
Materials and methods for the treatment of friedreich's ataxysis
ActiveAL13567BBiomedical engineeringCancer research
Owner:THE TRUSTEES OF INDIANA UNIV
Crystal forms of 5-(3,4-difluorobenzyl)8((1r,4r)4-methylcyclohexyl)6,9-dioxo2,5,8-triazaspyro[3.5]nonane2-carbaldhedy
ActiveAL13570BNonaneBenzyl group
Owner:CYTOKINETICS INC
Chimeric antigen receptors targeting b-cell maturation antigen
ActiveAL13561BAntigen receptorAntigen
Owner:THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY DEPARTMENT OF HEALTH & HUMAN SERVICES
Rodents having a restricted lambda light chain repertory expressed from the kappa locus and their uses
ActiveAL13540BGeneticsPhysics
Owner:REGENERON PHARMACEUTICALS INC
Dosage regimen with (s)-4,5-dihydro-2-[2-hydroxy-4-(3,6- dioxaheptyloxy)phenyl1-4-methyl-4-thiazolecarboxylic acid for use in the treatment of iron overload
ActiveAL13575BThiazoleOncology
Owner:ABFERO PHARMACEUTICALS INC +1
Processes for the production of industrial products from vegetable lipids
ActiveAL13568BBiotechnologyEngineering
Owner:NUSEED GLOBAL INNOVATION LTD
Diethyl-[6-(4-hydroxycarbamoyl-phenyl-carbamoyloxymethyl)-naphthalen-2-yl-methyl]-ammonium chloride combined with at least one glucocorticodortic for use in the treatment of muscular dystrophy
ActiveAL13566BMuscular dystrophyPhysiology
Owner:ITALFARMACO SPA
Roof earthquake resistance system and method for constructing load-bearing structures
ActiveAL13553BEarthquake resistanceGeotechnical engineering
Owner:BMI ITALIA SRL
Floating equipment for installation of photovoltaic panels in the open sea and installation method
ActiveAL13563BOpen seaEngineering physics
Owner:BLUENEWABLES SL
Combination comprising a thr-beta agonist and a glp-1r agonist for use in the treatment of obesity
ActiveAL13543BAgonistObesity
Owner:TERNS PHARMACEUTICALS INC
New therapeutic combinations containing pirfenidone and pde4 inhibitors for the treatment of progressive fibrosis interstitial lung diseases
ActiveAL13548BInterstitial lung diseasePDE4 Inhibitors
Owner:BOEHRINGER INGELHEIM INT GMBH
Preparations of coated blueberry granules with stable proanthocyanidin content
ActiveAL13557BProanthocyanidinOrganic chemistry
Owner:DOMPE FARMACEUTICI SPA
Crystal forms of a bruton's tyrosine kinase inhibitor
ActiveAL13532BMedicineTyrosine
Owner:PHARMACYCLICS LLC
Status dictation systems within an injection equipment group
ActiveAL13580BInjection equipmentAcoustics
Owner:ELI LILLY & CO
Thrb receptor agonist compound and method of preparation and use thereof
ActiveAL13564BAgonistPharmacology
Owner:TERNS PHARMACEUTICALS INC
Antitumoral, composition and method of its preparation and use
ActiveAL13550BOrganic chemistryAnti tumour
Owner:DUALITY BIOLOGICS (SUZHOU) CO LTD
Hepatitis b virus (HBV) dsrna agent compositions and methods of use thereof
ActiveAL13559BHepatitis B immunizationHepatitis B virus
Owner:ALNYLAM PHARMACEUTICALS INC